+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration



Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration



Journal of Neurology 246(Suppl. 2): II/6-II/15



Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are usually sporadic multisystem degenerations associated with filamentous tau inclusions in neurons and glia. As such they can be considered sporadic tauopathies in contrast to familial tauopathies linked to mutations in the tau gene. Mutations have not been found in the tau gene in either PSP or CBD. The clinical syndromes and neuroimaging of typical cases of PSP and CBD are distinct; however, atypical cases are described that have overlapping clinical and pathologic features. Both PSP and CBD have similar biochemical alterations in the tau protein, with the abnormal tau protein containing predominantly four-repeat tau. While there is overlap in the pathology in PSP and CBD, there are sufficient differences to continue the present day trend to consider these separate disorders. Several important pathologic features differentiate PSP from CBD. Ballooned neurons are frequent and nearly a sine qua non for CBD, but they are found in PSP at a frequency similar to that of other neurodegenerative diseases, such as Alzheimer's disease. Astrocytic lesions are different, with tufted astrocytes found in motor cortex and striatum in PSP and astrocytic plaques in focal atrophic cortices in CBD. The most characteristic neuronal tau pathology in CBD is wispy, fine filamentous inclusions within neuronal cell bodies, while affected neurons in PSP have compact, dense filamentous aggregates characteristic of globose neurofibrillary tangles. Thread-like processes in gray and white matter are much more numerous and widespread in CBD than in PSP. The brunt of the pathology in CBD is in the cerebrum, while the basal ganglia, diencephalon and brainstem are the targets of PSP. Further clinicopathologic studies will refine our understanding of these disorders and open the possibility that common etiologic factors may be identified for these unusual sporadic tauopathies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011048822

Download citation: RISBibTeXText

PMID: 10525997

DOI: 10.1007/bf03161076


Related references

Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. Journal of Neuropathology and Experimental Neurology 55(1): 53-67, 1996

A case manifested overlapping neuropathologic features of both progressive supranuclear palsy and corticobasal degeneration. Brain & Nerve (Tokyo) 50(3): 263-271, 1998

A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). No to Shinkei 50(3): 263-271, 1998

Corticobasal degeneration and progressive supranuclear palsy--differentiation by somatosensory-evoked potentials. No to Shinkei 48(3): 253-257, 1996

An unusual autopsy case of corticobasal degeneration--with special reference to clinicopathological differentiation from progressive supranuclear palsy and slowly progressive aphasia. No to Shinkei 48(6): 559-565, 1996

Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: Differentiation from progressive supranuclear palsy. Acta Neuropathologica 90(1): 37-43, 1995

Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. Journal of the Neurological Sciences 138(1-2): 66-77, 1996

Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. Journal of Neural Transmission. Supplementum 42: 79-90, 1994

Progressive supranuclear palsy and corticobasal degeneration. Bailliere's Clinical Neurology 6(1): 167-185, 1997

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. Journal of Neuropathology and Experimental Neurology 60(6): 647-657, 2001

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively exon 10 isoforms. Journal of Neurochemistry 72(3): 1243-1249, 1999

Treatment of progressive supranuclear palsy and corticobasal degeneration. Movement Disorders 20(Suppl. 12): S83-S91, 2005